{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:46:55Z","timestamp":1778633215346,"version":"3.51.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2009,6,30]],"date-time":"2009-06-30T00:00:00Z","timestamp":1246320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Gastroenterol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/ajg.2009.346","type":"journal-article","created":{"date-parts":[[2009,6,30]],"date-time":"2009-06-30T14:43:37Z","timestamp":1246373017000},"page":"2439-2448","source":"Crossref","is-referenced-by-count":71,"title":["Sustained Responders Have Better Quality of Life and Productivity Compared With Treatment Failures Long After Antiviral Therapy for Hepatitis C"],"prefix":"10.14309","volume":"104","author":[{"given":"Ava A","family":"John-Baptiste","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla C","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E Jenny","family":"Heathcote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Laporte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank H","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray D","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2009,6,30]]},"reference":[{"key":"BFajg2009346_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1023\/A:1008960710415","volume":"9","author":"L Kleinman","year":"2000","unstructured":"Kleinman L, Zodet MW, Hakim Z et al. Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Qual Life Res 2000;9:499\u2013508.","journal-title":"Qual Life Res"},{"issue":"Suppl 3","key":"BFajg2009346_CR2","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1097\/01.aids.0000192075.26314.87","volume":"19","author":"L Kramer","year":"2005","unstructured":"Kramer L, Hofer H, Bauer E et al. Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection. AIDS 2005;19 (Suppl 3): S85\u2013S92.","journal-title":"AIDS"},{"key":"BFajg2009346_CR3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1468-1293.2007.00505.x","volume":"8","author":"HH Thein","year":"2007","unstructured":"Thein HH, Maruff P, Krahn MD et al. Improved cognitive function as a consequence of hepatitis C virus treatment. HIV Medicine 2007;8:520\u2013528.","journal-title":"HIV Medicine"},{"key":"BFajg2009346_CR4","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/hep.510300504","volume":"30","author":"AJ Rodger","year":"1999","unstructured":"Rodger AJ, Jolley D, Thompson SC et al. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999;30:1299\u20131301.","journal-title":"Hepatology"},{"key":"BFajg2009346_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1046\/j.1525-1497.2003.20826.x","volume":"18","author":"S Zickmund","year":"2003","unstructured":"Zickmund S, Ho EY, Masuda M et al. They treated me like a leper\u201d. Stigmatization and the quality of life of patients with hepatitis C. J Gen Intern Med 2003;18:835\u2013844.","journal-title":"J Gen Intern Med"},{"key":"BFajg2009346_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/hep.20014","volume":"39","author":"O Dalgard","year":"2004","unstructured":"Dalgard O, Egeland A, Skaug K et al. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology 2004;39:74\u201380.","journal-title":"Hepatology"},{"key":"BFajg2009346_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0168-8278(01)00280-X","volume":"36","author":"RJ Fontana","year":"2002","unstructured":"Fontana RJ, Hussain KB, Schwartz SM et al. Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol 2002;36:401\u2013407.","journal-title":"J Hepatol"},{"key":"BFajg2009346_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0188-4409(03)00003-1","volume":"34","author":"JF Gallegos-Orozco","year":"2003","unstructured":"Gallegos-Orozco JF, Fuentes AP, Gerardo Argueta J et al. Health-related quality of life and depression in patients with chronic hepatitis C. Arch Med Res 2003;34:124\u2013129.","journal-title":"Arch Med Res"},{"key":"BFajg2009346_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.genhosppsych.2005.06.006","volume":"27","author":"J Golden","year":"2005","unstructured":"Golden J, O\u2019Dwyer AM, Conroy RM . Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Gen Hosp Psychiatry 2005;27:431\u2013438.","journal-title":"Gen Hosp Psychiatry"},{"key":"BFajg2009346_CR10","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1111\/j.1572-0241.2001.04133.x","volume":"96","author":"KB Hussain","year":"2001","unstructured":"Hussain KB, Fontana RJ, Moyer CA et al. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001;96:2737\u20132744.","journal-title":"Am J Gastroenterol"},{"key":"BFajg2009346_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/hep.510290124","volume":"29","author":"HL Bonkovsky","year":"1999","unstructured":"Bonkovsky HL, Woolley JM . Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999;29:264\u2013270.","journal-title":"Hepatology"},{"key":"BFajg2009346_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/hep.510300203","volume":"30","author":"JE Ware Jr","year":"1999","unstructured":"Ware JE Jr, Bayliss MS, Mannocchia M et al. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology 1999;30:550\u2013555.","journal-title":"Hepatology"},{"key":"BFajg2009346_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1478-3231.2008.01865.x","volume":"29","author":"PC Hsu","year":"2009","unstructured":"Hsu PC, Krajden M, Yoshida EM et al. Does cirrhosis affect quality of life in hepatitis C virus-infected patients? Liver Int 2009;29:449\u2013458.","journal-title":"Liver Int"},{"key":"BFajg2009346_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/gps.1041","volume":"19","author":"M Barber","year":"2004","unstructured":"Barber M, Stott DJ . Validity of the Telephone Interview for Cognitive Status (TICS) in post-stroke subjects. Int J Geriatr Psychiatry 2004;19:75\u201379.","journal-title":"Int J Geriatr Psychiatry"},{"key":"BFajg2009346_CR15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00391-005-0299-5","volume":"38","author":"D Debling","year":"2005","unstructured":"Debling D, Amelang M, Hasselbach P et al. Assessment of cognitive status in the elderly using telephone interviews. Z Gerontol Geriatr 2005;38:360\u2013367.","journal-title":"Z Gerontol Geriatr"},{"key":"BFajg2009346_CR16","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1572-0241.2003.07332.x","volume":"98","author":"CA Chong","year":"2003","unstructured":"Chong CA, Gulamhussein A, Heathcote EJ et al. Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol 2003;98:630\u2013638.","journal-title":"Am J Gastroenterol"},{"key":"BFajg2009346_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373\u2013383.","journal-title":"J Chronic Dis"},{"key":"BFajg2009346_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/00005650-199302000-00005","volume":"31","author":"S Greenfield","year":"1993","unstructured":"Greenfield S, Apolone G, McNeil BJ et al. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care 1993;31:141\u2013154.","journal-title":"Med Care"},{"key":"BFajg2009346_CR19","volume-title":"SF-36 Health Survey Manual and Interpretation Guide","author":"JE Ware Jr","year":"1993","unstructured":"Ware JE Jr, Snow KK, Kosinski M et al. SF-36 Health Survey Manual and Interpretation Guide. New England Medical Centre, The Health Institute: Boston, MA, 1993."},{"key":"BFajg2009346_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1023\/A:1008884805251","volume":"7","author":"MS Bayliss","year":"1998","unstructured":"Bayliss MS, Gandek B, Bungay KM et al. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res 1998;7:39\u201355.","journal-title":"Qual Life Res"},{"key":"BFajg2009346_CR21","first-page":"3S","volume":"29","author":"MS Bayliss","year":"1999","unstructured":"Bayliss MS . Methods in outcomes research in hepatology: definitions and domains of quality of life. Hepatology 1999;29:3S\u20136S.","journal-title":"Hepatology"},{"key":"BFajg2009346_CR22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2165\/00019053-199507060-00004","volume":"7","author":"D Feeny","year":"1995","unstructured":"Feeny D, Furlong W, Boyle M et al. Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics 1995;7:490\u2013502.","journal-title":"Pharmacoeconomics"},{"key":"BFajg2009346_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier J, Roberts J, Deverill M . The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271\u2013292.","journal-title":"J Health Econ"},{"key":"BFajg2009346_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jhealeco.2006.09.002","volume":"26","author":"SA Kharroubi","year":"2007","unstructured":"Kharroubi SA, Brazier JE, Roberts J et al. Modelling SF-6D health state preference data using a nonparametric Bayesian method. J Health Econ 2007;26:597\u2013612.","journal-title":"J Health Econ"},{"key":"BFajg2009346_CR25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0021-9681(87)90019-1","volume":"40","author":"GW Torrance","year":"1987","unstructured":"Torrance GW . Utility approach to measuring health-related quality of life. J Chronic Dis 1987;40:593\u2013603.","journal-title":"J Chronic Dis"},{"key":"BFajg2009346_CR26","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1377\/hlthaff.25.4.1133","volume":"25","author":"C Sanmartin","year":"2006","unstructured":"Sanmartin C, Berthelot JM, Ng E et al. Comparing health and health care use in Canada and the United States. Health Affairs 2006;25:1133\u20131142.","journal-title":"Health Affairs"},{"key":"BFajg2009346_CR27","first-page":"265","volume":"163","author":"WM Hopman","year":"2000","unstructured":"Hopman WM, Towheed T, Anastassiades T et al. Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group.[see comment]. CMAJ 2000;163:265\u2013271.","journal-title":"CMAJ"},{"key":"BFajg2009346_CR28","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1097\/MLR.0b013e31814848f1","volume":"45","author":"DG Fryback","year":"2007","unstructured":"Fryback DG, Dunham NC, Palta M et al. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care 2007;45:1162\u20131170.","journal-title":"Med Care"},{"key":"BFajg2009346_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2165\/00019053-200321050-00005","volume":"21","author":"J Rasenack","year":"2003","unstructured":"Rasenack J, Zeuzem S, Feinman SV et al. Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C. Pharmacoeconomics 2003;21:341\u2013349.","journal-title":"Pharmacoeconomics"},{"key":"BFajg2009346_CR30","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1136\/gut.2007.142844","volume":"57","author":"B Helbling","year":"2008","unstructured":"Helbling B, Overbeck K, Gonvers JJ et al. Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection. Gut 2008;57:1597\u20131603.","journal-title":"Gut"},{"key":"BFajg2009346_CR31","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1572-0241.2005.40976.x","volume":"100","author":"HH Thein","year":"2005","unstructured":"Thein HH, Krahn M, Kaldor JM et al. Estimation of utilities for chronic hepatitis C from SF-36 scores. Am J Gastroenterol 2005;100:643\u2013651.","journal-title":"Am J Gastroenterol"},{"key":"BFajg2009346_CR32","first-page":"1","volume":"10","author":"M Wright","year":"2006","unstructured":"Wright M, Grieve R, Roberts J et al. Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation. Health Technol Assess (Winchester, England) 2006;10:1\u2013113.","journal-title":"Health Technol Assess (Winchester, England)"},{"key":"BFajg2009346_CR33","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S1590-8658(00)80260-1","volume":"32","author":"G Bianchi","year":"2000","unstructured":"Bianchi G, Loguercio C, Sgarbi D et al. Reduced quality of life in patients with chronic hepatitis C: effects of interferon treatment. Dig Liver Dis 2000;32:398\u2013405.","journal-title":"Dig Liver Dis"},{"key":"BFajg2009346_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00004836-200603000-00009","volume":"40","author":"S Zacks","year":"2006","unstructured":"Zacks S, Beavers K, Theodore D et al. Social stigmatization and hepatitis C virus infection. J Clin Gastroenterol 2006;40:220\u2013224.","journal-title":"J Clin Gastroenterol"},{"key":"BFajg2009346_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0168-8278(00)00026-X","volume":"34","author":"JG McHutchison","year":"2001","unstructured":"McHutchison JG, Ware JE Jr, Bayliss MS et al. The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol 2001;34:140\u2013147.","journal-title":"J Hepatol"},{"key":"BFajg2009346_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1155\/2006\/638272","volume":"20","author":"M Witkos","year":"2006","unstructured":"Witkos M, Yi QL, Heathcote J et al. Predictors of antiviral therapy in a post-transfusion cohort of hepatitis C patients. Can J Gastroenterol 2006;20:107\u2013111.","journal-title":"Can J Gastroenterol"},{"key":"BFajg2009346_CR37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.drugpo.2007.01.009","volume":"18","author":"J Grebely","year":"2007","unstructured":"Grebely J, Genoway K, Khara M et al. Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection. Int J Drug Policy 2007;18:437\u2013443.","journal-title":"Int J Drug Policy"}],"container-title":["The American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2009346.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2009346","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ajg.2009.346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2009346.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T11:26:49Z","timestamp":1643196409000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000434-200910000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,30]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["BFajg2009346"],"URL":"https:\/\/doi.org\/10.1038\/ajg.2009.346","relation":{},"ISSN":["0002-9270","1572-0241"],"issn-type":[{"value":"0002-9270","type":"print"},{"value":"1572-0241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,30]]}}}